BestStocksBeta
Market closed · After hours · 5:57 PM ET
Last update: Nov 4, 2026, 5:23 PM ET
Medline Inc.
$40.35▲ 18.36% today
After Hours

Why Medline Inc. (MDLN) stock moved

Updated Nov 4, 2026

Medline Inc. (MDLN) shares climbed 18.4% to $40.35 as of November 4, 2026, a sharp gain from the prior close of $34.09. BestStocks flagged the session as a major change for MDLN. The move is tied to an earnings beat. Below, we break down what changed for MDLN, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Earnings Beat

Medline Inc. (MDLN) reported EPS of $0.44 vs. consensus estimate of $0.34 for Q3 FY2026, beating consensus by 28.2%. Monitor full Q3 FY2026 results (revenue, margin trends, guidance) when reported, and any management commentary on demand trends and forward outlook.

This summary describes the catalyst and move as first detected on Nov 4, 2026, 10:08 AM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
Material / EarningsHigh confidence
Rel. volume
3.2×
Extreme
Vs peers
—
No comparable peers
Market cap
$35.4B
NASDAQ Global Select
Analyst target
$44
+9.5% vs price
Price chart
Oct 5 – Nov 4
VENNNNNVNNNNNN$32$36$40Oct 5Oct 13Oct 20Oct 28Nov 4
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Medline Inc. investors

For Medline Inc. investors, the balance of recent signals points to a strong bullish shift. On the constructive side: Earnings beat with positive market reaction; Strong 18.4% price move with conviction. Weighing against that: Medline Inc. (MDLN) declined 2.02% to $33.01 as investor sentiment remains pressured by ongoing fallout from a strategic product segment exit and securities fraud investigation. Wall Street's consensus price target sits at $44.20, implying +9.5% upside from $40.35. BestStocks rates the overall signal quality high (90/100). With earnings roughly 112 days out, the next report is the most likely near-term test of the move.

MDLN price reaction

MDLN last traded at $40.35, up $6.26 (+18.36%) from the previous close of $34.09. The session traded on 3.2× average volume (extreme), so the move carried above-average conviction. Over the past month the stock has ranged between $32.00 and $40.35, and it currently sits about 100% of the way up that band.

Bullish and bearish analyst opinions on Medline Inc. (MDLN)

Latest catalyststrengthens the bull case
The latest catalyst — an earnings beat the market rewarded — it strengthens the bull case and confirms the prevailing bullish analyst lean.

The consensus analyst price target on Medline Inc. (MDLN) is $44.20, 9.5% above the recent $40.35. Over the past 90 days analysts logged 0 upgrades, 12 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MDLN line up.

The bullish case

  • Wall Street's consensus price target of $44.20 implies +9.5% upside from $40.35.
  • The Street's most bullish target is $55.00 (+36.3%).
  • Earnings beat with positive market reaction.
  • Strong 18.4% price move with conviction.
  • Volume 3.2x average — institutional conviction.

The bearish case

  • The most bearish analyst target is $37.00 (-8.3%).
  • Medline Inc. (MDLN) declined 2.02% to $33.01 as investor sentiment remains pressured by ongoing fallout from a strategic product segment exit and securities fraud investigation.
Bull vs bear balanceStrong Bullish Shift
BearishNeutralBullish
The latest catalyst moved the balance toward the bulls — the hollow tick marks where it sat before.

Weighing both sides, BestStocks' composite read of recent signals is strongly bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 4, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $44+9.5%
= 12 maintains
Mizuho maintained Outperform · 2026-10-22
SEC filings watch
8-K2026-11-04
Material event — review for impact
high
10-Q2026-11-04
Quarterly financial results
medium
8-K2026-10-21
Material event — review for impact
high
8-K2026-10-15
Material event — review for impact
high
Peer context
MDLN+18.4%

Previous notable changes for MDLN

Activity2026-11-04+18.4%via zacks.com ↗
Medline reported Q3 2026 earnings (Globe Newswire, Nov 4), driving a +13.02% intraday surge from $34.09 to $38.53. Volume reached 4.07M shares (2.54x historical average at this time of day), signaling strong investor response to the results announcement.
News2026-11-02+4.7%
Medline CEO Jim Boyle will present at the Jefferies Global Healthcare Conference on November 17, 2026.
News2026-10-30+0.4%
Bleichmar Fonti & Auld LLP launches securities fraud investigation into Medline over product quality issues amid stock decline.
News2026-10-29-1.1%
Pomerantz Law Firm launches investor investigation into Medline Inc., suggesting potential securities litigation claims.
Upcoming catalysts & outlook
Next earnings
2027-02-24 (est.)
in 112 days
Earnings Release
2027-02-24
High impact
Thesis shift
Strong Bullish Shift
bullish signal
Risk level
Medium
from change events

Frequently asked questions about MDLN

Why did Medline Inc. (MDLN) stock move?

MDLN climbed 18.4% to $40.35. The move is associated with an earnings beat.

How much did MDLN stock rise?

MDLN gained 18.36% ($6.26) versus the prior close of $34.09, last trading at $40.35 on 3.2× average volume.

When is Medline Inc.'s next earnings date?

MDLN's next earnings report is estimated for 2027-02-24 — about 112 days away.

What is the analyst price target for MDLN?

The consensus analyst price target for MDLN is $44.20, about 9.5% above the current $40.35. Over the past 90 days, analysts recorded 0 upgrades, 12 maintains, and 0 downgrades.

How BestStocks tracks MDLN

This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 20 tracked change events for MDLN, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 4, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataFMP earnings & estimatesCompany news feedsAnalyst ratings & price targets (FMP)SEC EDGAR filingsEarnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.